Endocrinology, Vol 126, 118-124, Copyright © 1990 by Endocrine Society

ARTICLES

Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure

DT van den Berg, ER de Kloet, HH van Dijken and W de Jong
Rudolf Magnus Institute for Pharmacology, University of Utrecht, The Netherlands.

Systolic blood pressure was measured, using an indirect tail method, in conscious male rats at several time intervals after the intracerebroventricular injection of mineralo-and glucocorticoid agonists and antagonists. Intracerebroventricular administration of the antimineralocorticoid RU 28318 (10 ng) decreased blood pressure, while the antiglucocorticoid RU 38486 (10 ng) caused an increase, which was slower in onset and of longer duration. The effect of the antimineralocorticoid was maximal at 8 h and had disappeared after 24 h. The antiglucocorticoid had a significant effect 24 and 48 h after injection. Neither antagonist was effective when administered sc at the same dose (10 ng). Intracerebroventricular administration of aldosterone (10 ng) and the selective glucocorticoid agonist RU 28362 (10 ng) increased and decreased blood pressure, respectively. Corticosterone given intracerebroventricularly (10-100 ng) did not affect blood pressure unless the dose was increased to 1 microgram. Two weeks after adrenalectomy a decrease in blood pressure was observed when the rats were given 0.9% saline instead of water to drink. Replacement therapy with corticosterone (12.5-mg steroid pellet, sc) restored blood pressure to the level in the sham-operated controls. The chronically elevated level of circulating corticosterone produced by a 100-mg sc corticosterone pellet increased blood pressure. The 12.5-and 100-mg sc corticosterone pellets resulted in plasma corticosterone levels of approximately 3 and 20 micrograms/100 ml, respectively. Intracerebroventricular administration of the glucocorticoid and mineralocorticoid antagonists (10 ng) increased and decreased, respectively, the blood pressure of the adrenalectomized rats receiving corticosterone substitution. From these data we conclude that corticosteroids can affect the central regulation of blood pressure. The mineralo- and glucocorticoids have opposite effects, which differ in onset and duration. The mineralocorticoids increased blood pressure, whereas the glucocorticoid decreased it.

This article has been cited by other articles:

				D. A. Scheuer, A. G. Bechtold, and K. A. Vernon Chronic Activation of Dorsal Hindbrain Corticosteroid Receptors Augments the Arterial Pressure Response to Acute Stress Hypertension, January 1, 2007; 49(1): 127 - 133. [Abstract] [Full Text] [PDF]

				A. G. Bechtold and D. A. Scheuer Glucocorticoids act in the dorsal hindbrain to modulate baroreflex control of heart rate Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R1003 - R1011. [Abstract] [Full Text] [PDF]

				S. Banjanin, A. Kapoor, and S. G. Matthews Prenatal glucocorticoid exposure alters hypothalamic-pituitary-adrenal function and blood pressure in mature male guinea pigs J. Physiol., July 1, 2004; 558(1): 305 - 318. [Abstract] [Full Text] [PDF]

				D. A. Scheuer, A. G. Bechtold, S. S. Shank, and S. F. Akana Glucocorticoids act in the dorsal hindbrain to increase arterial pressure Am J Physiol Heart Circ Physiol, January 1, 2004; 286(1): H458 - H467. [Abstract] [Full Text] [PDF]

				S. K. Droste, A. Gesing, S. Ulbricht, M. B. Muller, A. C. E. Linthorst, and J. M. H. M. Reul Effects of Long-Term Voluntary Exercise on the Mouse Hypothalamic-Pituitary-Adrenocortical Axis Endocrinology, July 1, 2003; 144(7): 3012 - 3023. [Abstract] [Full Text] [PDF]

				S. S. Shank and D. A. Scheuer Glucocorticoids reduce responses to AMPA receptor activation and blockade in nucleus tractus solitarius Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1751 - H1761. [Abstract] [Full Text] [PDF]

				K. Rahmouni, M. Barthelmebs, M. Grima, J.-L. Imbs, and W. De Jong Involvement of Brain Mineralocorticoid Receptor in Salt-Enhanced Hypertension in Spontaneously Hypertensive Rats Hypertension, October 1, 2001; 38(4): 902 - 906. [Abstract] [Full Text] [PDF]

				W Shamim, M Yousufuddin, D P Francis, P Gualdiero, J W Honour, S D Anker, and A J S Coats Raised urinary glucocorticoid and adrenal androgen precursors in the urine of young hypertensive patients: possible evidence for partial glucocorticoid resistance Heart, August 1, 2001; 86(2): 139 - 144. [Abstract] [Full Text] [PDF]

				D. M. Roesch, Y. Tian, W. Zheng, M. Shi, J. G. Verbalis, and K. Sandberg Estradiol Attenuates Angiotensin-Induced Aldosterone Secretion in Ovariectomized Rats Endocrinology, December 1, 2000; 141(12): 4629 - 4636. [Abstract] [Full Text] [PDF]

				C. Dodt, B. Keyser, M. Molle, H. L. Fehm, and M. Elam Acute Suppression of Muscle Sympathetic Nerve Activity by Hydrocortisone in Humans Hypertension, March 1, 2000; 35(3): 758 - 763. [Abstract] [Full Text] [PDF]

				K. Rahmouni, M. Barthelmebs, M. Grima, J.-L. Imbs, and W. De Jong Brain Mineralocorticoid Receptor Control of Blood Pressure and Kidney Function in Normotensive Rats Hypertension, May 1, 1999; 33(5): 1201 - 1206. [Abstract] [Full Text] [PDF]

				J. L. Segar, E. R. Lumbers, A. M. Nuyt, O. J. Smith, and J. E. Robillard Effect of antenatal glucocorticoids on sympathetic nerve activity at birth in preterm sheep Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1998; 274(1): R160 - R167. [Abstract] [Full Text] [PDF]

				D. S. Gardner, A. A. Jackson, and S. C. Langley-Evans Maintenance of Maternal Diet-Induced Hypertension in the Rat Is Dependent on Glucocorticoids Hypertension, December 1, 1997; 30(6): 1525 - 1530. [Abstract] [Full Text]

				M. A. Magiakou, G. Mastorakos, K. Zachman, and G. P. Chrousos Blood Pressure in Children and Adolescents with Cushing's Syndrome before and after Surgical Cure J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1734 - 1738. [Abstract] [Full Text] [PDF]